Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489908 | SCV000576533 | uncertain significance | not provided | 2017-04-28 | criteria provided, single submitter | clinical testing | A second variant of uncertain significance has been identified in the NEBL gene. The M276T variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed in 5/10,380 (0.05%) alleles from individuals of African ancestry in the Exome Aggregation Consortium (ExAC) dataset (Lek et al., 2016; Exome Variant Server). This substitution occurs at a position that is not conserved across species and threonine is present as the wild type in at least one mammalian species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Nevertheless, the M276T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. |
Labcorp Genetics |
RCV001088677 | SCV000749709 | likely benign | Primary dilated cardiomyopathy | 2023-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023238 | SCV002679176 | uncertain significance | not specified | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.827T>C (p.M276T) alteration is located in exon 9 (coding exon 9) of the NEBL gene. This alteration results from a T to C substitution at nucleotide position 827, causing the methionine (M) at amino acid position 276 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |